Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 GBX | 0.00% | 0.00% | -5.88% |
Apr. 25 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
Apr. 23 | N4 Pharma loss widens but "great optimism" remains | AN |
Sales 2022 | - | Sales 2023 | 1.95K 2.45K | Capitalization | 2.28M 2.87M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.26M | Net income 2023 | -1M -1.26M | EV / Sales 2022 | - |
Net cash position 2022 | 1.92M 2.41M | Net cash position 2023 | 1.03M 1.29M | EV / Sales 2023 | 644 x |
P/E ratio 2022 |
-3.35
x | P/E ratio 2023 |
-1.63
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.72% |
Latest transcript on N4 Pharma Plc
1 month | -5.88% | ||
3 months | +6.67% | ||
6 months | -8.57% | ||
Current year | -5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 13-12-31 | |
David Templeton
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 46 | 20-07-13 | |
Founder | 59 | 13-12-31 | |
Chris Britten
CHM | Chairman | - | 19-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.8 | 0.00% | 66 185 |
24-05-10 | 0.8 | 0.00% | 50,000 |
24-05-09 | 0.8 | 0.00% | 371,490 |
24-05-08 | 0.8 | 0.00% | 107,621 |
24-05-07 | 0.8 | 0.00% | 72,162 |
Delayed Quote London S.E., May 13, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.88% | 2.69M | |
+29.90% | 684B | |
+30.34% | 568B | |
-4.05% | 361B | |
+18.07% | 329B | |
+4.25% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.92% | 166B |
- Stock Market
- Equities
- ONZ Stock